[go: up one dir, main page]

IL124293A0 - Method and compositions for the reduction of xenotransplantation rejection - Google Patents

Method and compositions for the reduction of xenotransplantation rejection

Info

Publication number
IL124293A0
IL124293A0 IL12429396A IL12429396A IL124293A0 IL 124293 A0 IL124293 A0 IL 124293A0 IL 12429396 A IL12429396 A IL 12429396A IL 12429396 A IL12429396 A IL 12429396A IL 124293 A0 IL124293 A0 IL 124293A0
Authority
IL
Israel
Prior art keywords
compositions
reduction
xenotransplantation rejection
xenotransplantation
rejection
Prior art date
Application number
IL12429396A
Original Assignee
Mount Sinai Medical Center
Austin Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai Medical Center, Austin Research Inst filed Critical Mount Sinai Medical Center
Publication of IL124293A0 publication Critical patent/IL124293A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12429396A 1995-11-03 1996-11-01 Method and compositions for the reduction of xenotransplantation rejection IL124293A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US620095P 1995-11-03 1995-11-03
PCT/US1996/017695 WO1997016064A1 (en) 1995-11-03 1996-11-01 Methods and compositions for the reduction of xenotransplantation rejection

Publications (1)

Publication Number Publication Date
IL124293A0 true IL124293A0 (en) 1998-12-06

Family

ID=21719767

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12429396A IL124293A0 (en) 1995-11-03 1996-11-01 Method and compositions for the reduction of xenotransplantation rejection

Country Status (5)

Country Link
EP (1) EP0877549A4 (en)
JP (1) JP2000514641A (en)
AU (1) AU7668696A (en)
IL (1) IL124293A0 (en)
WO (1) WO1997016064A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1581899A (en) * 1997-10-28 1999-05-17 Biotransplant Incorporated Nuclear transfer for production of transgenic animal embryo
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
CA2507486A1 (en) 2002-08-14 2004-02-26 Immerge Biotherapeutics, Inc. .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom
AU2003295322B2 (en) 2002-08-21 2009-06-18 Revivicor, Inc. Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
WO2005047469A2 (en) 2003-11-05 2005-05-26 University Of Pittsburgh PORCINE ISOGLOBOSIDE 3 SYNTHASE PROTEIN, cDNA, GENOMIC ORGANIZATION, AND REGULATORY REGION
CN104721883A (en) 2004-03-17 2015-06-24 雷维维科公司 Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase
ES2538819T3 (en) 2009-07-30 2015-06-24 F. Hoffmann-La Roche Ag Enzymatic antibody processing
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
SG188605A1 (en) 2010-10-05 2013-04-30 Hoffmann La Roche Antibodies against human tweak and uses thereof
SG2014012470A (en) 2011-10-05 2014-06-27 Hoffmann La Roche Process for antibody g1 glycoform production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356804A (en) * 1990-10-24 1994-10-18 Mount Sinai School Of Medicine Of The City Of New York Cloning and expression of biologically active human α-galactosidase A
CA2187802A1 (en) * 1994-04-13 1995-10-26 Manfred W. Baetscher .alpha.(1,3) galactosyltransferase negative swine
CA2192660A1 (en) * 1994-06-15 1995-12-21 Mauro S. Sandrin Methods for reducing hyperacute rejection of xenografts

Also Published As

Publication number Publication date
EP0877549A1 (en) 1998-11-18
WO1997016064A1 (en) 1997-05-09
JP2000514641A (en) 2000-11-07
EP0877549A4 (en) 2002-01-02
AU7668696A (en) 1997-05-22

Similar Documents

Publication Publication Date Title
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
IL117872A0 (en) Herbicidal compositions and method of their use
EG20992A (en) Container and method of making the same
GB9422571D0 (en) Haemorrihoidal compositions and method of use
EP0777753A4 (en) Method of making metals and other elements
EP0711029A3 (en) Microstructure and method of forming the same
ZA968322B (en) Solid sillicone compositions and methods for their preparation and use
PL321935A1 (en) Electroplating compositions and methods
PH31270A (en) Superplasticizer-concrete composition and method of preparation.
GB9504495D0 (en) Method and composition
IL109656A0 (en) Process for the manufacture of androstane-17-carbothioates and androstane-17-carbothioates prepared thereby
IL111186A (en) Process for the preparation of microspheres and microspheres made thereby
IL124293A0 (en) Method and compositions for the reduction of xenotransplantation rejection
GB9624501D0 (en) Insecticial compositions and method
GB9824335D0 (en) Mirror and method of making the same
GB2304576B (en) Reduction of airborne contaminants
EP0788425A4 (en) Belt construction and method of making the same
GB2300639B (en) Polyurethane compositions and method
GB9508546D0 (en) Method and composition
GB2290250B (en) Reforged flight bar and method of making the same
GB9414888D0 (en) Method and composition
GB9419087D0 (en) Method and composition
EP0745632A3 (en) Organosilicon compounds and method for the preparation thereof
HUT75422A (en) Gypsbonded forms and method for making thereof
EP0768680A3 (en) Wire and method of preparing the same